Sheryl M. Green

The RESPOND trial: protocol for a novel phase-based psychotherapy and integrated neurobiological investigation of depression following early life adversity

Exposure to early life adversity (ELA) is one of the most robust predictors of future psychiatric illness. Among individuals assigned female at birth (AFAB), ELA can alter neuroendocrine, epigenetic, and inflammatory processes in ways that increase sensitivity to reproductive hor...